News

DocGo Expands Cardiac Monitoring Services with New Contract

DocGo Expands Cardiac Monitoring Services with New Contract

DocGo's New Contract to Enhance Remote Cardiac Monitoring

DocGo Inc. (Nasdaq: DCGO), a recognized leader in technology-enabled mobile health services, has taken a significant step forward by entering into a contract with a prominent hospital system in Mississippi. This agreement marks a pivotal expansion for DocGo, specifically through its subsidiary Cardiac RMS, as it seeks to provide state-of-the-art remote monitoring solutions tailored for adult and pediatric patients.

Innovative Care for Cardiac Patients

Beginning early in the near future, Cardiac RMS by DocGo plans to initiate remote monitoring services for approximately 3,000 patients equipped with cardiac implantable electronic devices (CIEDs). This contract signifies Cardiac RMS’s debut in Mississippi, simultaneously expanding its pediatric service offerings. It underscores the company’s dedication to providing comprehensive monitoring solutions that cater to patients of all ages in new regions.

Tackling Health Challenges in Mississippi

In Mississippi, high rates of cardiovascular conditions represent a pressing public health issue compounded by limited access to specialized healthcare, particularly in rural locales. The healthcare landscape here is often challenged by provider shortages, creating barriers to timely and effective patient care. By enabling remote monitoring, Cardiac RMS will significantly decrease the frequency of in-person visits, facilitating easier and earlier interventions that could prevent complications. This move aims to improve clinical efficiency, minimizing hospital readmissions and enhancing patient outcomes.

Transforming Healthcare Delivery

Lee Bienstock, CEO of DocGo, highlighted the growing trend among health systems to seek solutions that prioritize patient-centered care while optimizing resource management. Bienstock emphasized the importance of partnerships like that with Cardiac RMS, which ensure consistent oversight of patients using cardiac devices. This proactive approach not only reduces the risk of complications but also decreases hospitalization rates while bolstering operational efficiency. As such, this collaboration can be seen as a key component of a modern healthcare strategy aimed at delivering value-based care.

Remote Monitoring Capabilities

Through this new initiative, Cardiac RMS by DocGo will oversee patients with a variety of cardiac devices, including pacemakers, implantable cardioverter-defibrillators, heart failure devices, and implantable loop recorders. These devices necessitate regular monitoring to guarantee their proper function and to promptly address any potential issues. This ongoing oversight evident in remote monitoring is crucial for patient safety and quality of care.

About Cardiac RMS by DocGo

Cardiac RMS LLC is specialized in providing clinical services that focus on the remote monitoring of cardiac implantable electronic devices, along with virtual care management and remote physiologic monitoring (RPM). By bolstering care accessibility and enhancing the patient experience through remote solutions, Cardiac RMS is committed to helping healthcare providers deliver highly effective, patient-centric care that improves health outcomes and reduces overall costs.

About DocGo

DocGo is at the forefront of the proactive healthcare revolution, featuring an advanced care delivery platform encompassing a range of mobile health and remote monitoring services. The company’s mission is to transform the conventional healthcare model by making high-quality, accessible care available to patients wherever they may need it. Their innovative approach, supported by a skilled team of certified health professionals, improves care quality while enhancing efficiency for healthcare facilities and insurers. DocGo's comprehensive services enable seamless healthcare delivery in patients’ homes or workplaces, effectively bridging the gap between traditional and virtual care.

Frequently Asked Questions

What does the new contract mean for DocGo and Cardiac RMS?

This contract represents a significant expansion of Cardiac RMS’s services into Mississippi, allowing for enhanced remote monitoring for a large number of patients.

How many patients will benefit from these services?

Nearly 3,000 patients with cardiac implantable electronic devices will receive remote monitoring through Cardiac RMS.

Why is remote monitoring important in Mississippi?

The state faces numerous health challenges, including high cardiovascular disease rates and limited access to specialized care, making remote monitoring essential for timely interventions.

What types of devices will be monitored?

Cardiac RMS will monitor various devices including pacemakers, implantable cardioverter-defibrillators, and heart failure devices, ensuring their proper functioning and addressing any issues promptly.

What is DocGo's overall mission?

DocGo aims to revolutionize healthcare delivery by providing accessible, high-quality services that bridge the gap between physical and virtual care, enhancing patient experiences and outcomes.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 469

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 181

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 848

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 63

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 150

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 117

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 423

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 734

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 256

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 176

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading

Top 5 Most Recently Viewed Articles

MacGregor's Bold Play: RoRo Tech for TT-Line's Ferries

Updated Category News Views 51

A Green Wave in the Baltic It looks like MacGregor's betting big on the future of maritime transport, and they're putting their chips down on TT-Line's next-gen battery-hybrid LNG ferries. With a contract fresh out of the oven, they've signed up to kit out these eco-warriors with a range of RoRo equipment. And let me tell you, this is no piddly order—by any stretch,...

Continue Reading
WAVE Life Sciences: Rising Share Value Amid DMD Innovations

Updated Category News Views 50

Recent Developments at WAVE Life Sciences B.Riley has maintained a Buy rating on WAVE Life Sciences (NASDAQ: WVE) and raised the price target to $19 from $11. This adjustment comes after the promising announcement regarding the company's Duchenne muscular dystrophy (DMD) drug candidate, WVE-N531. Promising DMD Drug Candidate The company's analyst highlighted an increase...

Continue Reading
First American Uranium Successfully Secures $2.86 Million Funding

Updated Category News Views 143

First American Uranium Secures Oversubscribed Financing First American Uranium Inc. is thrilled to announce the closing of its oversubscribed flow-through share financing, having raised an impressive $2.86 million from issuing a total of 2,073,262 flow-through shares. Each share was priced at $1.38, exceeding initial expectations. Funding Utilization for Exploration The...

Continue Reading
Community Healthcare Trust Reports Q2 Financial Results

Updated Category News Views 161

Summary of Financial Results Community Healthcare Trust Incorporated (NYSE: CHCT) recently announced its financial performance for the quarter ending June 30, 2025. The company reported a net loss of approximately $12.6 million or $0.50 per diluted common share. The funds from operations ("FFO") and adjusted funds from operations ("AFFO") during this period amounted to...

Continue Reading
Neuberger Fund Ups Distribution Amid Market Challenges

Updated Category News Views 169

Neuberger Boosts Distribution: What's Driving This? I ain't about to sugarcoat it: the Neuberger Next Generation Connectivity Fund (NYSE: NBXG) decided to jack up its monthly distribution rate to $0.132 per share. This announcement, hitting wallets on November 30, 2026, has a record and ex-date of November 16. Now, that's a good ol' reliable payout for folks holding NBXG...

Continue Reading